XGN
USDExagen Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$11.080
High
$11.500
Low
$10.500
Volume
1.42M
Company Fundamentals
Market Cap
237.0M
Industry
Diagnostics & Research
Country
United States
Trading Stats
Avg Volume
0.23M
Exchange
NGM
Currency
USD
52-Week Range
Related News
BTIG Maintains Buy on Exagen, Raises Price Target to $15
BTIG analyst Mark Massaro maintains Exagen with a Buy and raises the price target from $13 to $15.
Exagen Inc. Reports Strong Q3 2025 Results
CARLSBAD, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2025, and recent
Canaccord Genuity Maintains Buy on Exagen, Raises Price Target to $15
Canaccord Genuity analyst Kyle Mikson maintains Exagen with a Buy and raises the price target from $11 to $15.
Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence
CARLSBAD, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing, announced today the acceptance of six abstracts at the 2025 American College of Rheumatology's
BTIG Maintains Buy on Exagen, Raises Price Target to $13
BTIG analyst Mark Massaro maintains Exagen with a Buy and raises the price target from $11 to $13.
Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025
CARLSBAD, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended September 30, 2025, before the
Related Stocks
MTZ
MasTec Inc.
DGX
Quest Diagnostics Incorporated
ACRE
Ares Commercial Real Estate Corporation
VRDN
Viridian Therapeutics Inc.
JQC
Nuveen Credit Strategies Income Fund Shares of Beneficial Interest
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.